These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8968386)

  • 1. Single-domain angiotensin I converting enzyme (kininase II): characterization and properties.
    Deddish PA; Wang LX; Jackman HL; Michel B; Wang J; Skidgel RA; Erdös EG
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1582-9. PubMed ID: 8968386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors.
    Georgiadis D; Beau F; Czarny B; Cotton J; Yiotakis A; Dive V
    Circ Res; 2003 Jul; 93(2):148-54. PubMed ID: 12805239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE.
    Ceconi C; Francolini G; Olivares A; Comini L; Bachetti T; Ferrari R
    Eur J Pharmacol; 2007 Dec; 577(1-3):1-6. PubMed ID: 17716647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined use of selective inhibitors and fluorogenic substrates to study the specificity of somatic wild-type angiotensin-converting enzyme.
    Jullien ND; Cuniasse P; Georgiadis D; Yiotakis A; Dive V
    FEBS J; 2006 Apr; 273(8):1772-81. PubMed ID: 16623712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Angiotensin converting enzyme (kininase II). Molecular and physiological aspects].
    Costerousse O; Jaspard E; Allegrini J; Wei L; Alhenc-Gelas F
    C R Seances Soc Biol Fil; 1992; 186(6):586-98. PubMed ID: 1339589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of rate constants for reactions of pulmonary microvascular angiotensin converting enzyme with an inhibitor and a substrate in vivo.
    Ryan JW; Valido FA; Sequeira MJ; Chung AY; Berryer P; Chen XL; Catravas JD
    J Pharmacol Exp Ther; 1994 Jul; 270(1):260-8. PubMed ID: 8035324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural determinants of RXPA380, a potent and highly selective inhibitor of the angiotensin-converting enzyme C-domain.
    Georgiadis D; Cuniasse P; Cotton J; Yiotakis A; Dive V
    Biochemistry; 2004 Jun; 43(25):8048-54. PubMed ID: 15209500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme.
    Grinshtein SV; Binevski PV; Gomazkov OA; Pozdnev VF; Nikolskaya II; Kost OA
    Biochemistry (Mosc); 1999 Aug; 64(8):938-44. PubMed ID: 10498812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of domain-selective angiotensin I-converting enzyme inhibitors.
    Redelinghuys P; Nchinda AT; Sturrock ED
    Ann N Y Acad Sci; 2005 Nov; 1056():160-75. PubMed ID: 16387685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of new peptide inhibitors on the ratio of angiotensin I-converting and kinin-degrading activities of dipeptidyl carboxypeptidase (angiotensin-converting enzyme).
    Kalinina EV; Posdnev VF; Komissarova NV; Gomazkov OA
    Biochemistry (Mosc); 1997 Mar; 62(3):247-50. PubMed ID: 9275297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RXP 407, a selective inhibitor of the N-domain of angiotensin I-converting enzyme, blocks in vivo the degradation of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro with no effect on angiotensin I hydrolysis.
    Junot C; Gonzales MF; Ezan E; Cotton J; Vazeux G; Michaud A; Azizi M; Vassiliou S; Yiotakis A; Corvol P; Dive V
    J Pharmacol Exp Ther; 2001 May; 297(2):606-11. PubMed ID: 11303049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Domain angiotensin I-converting enzyme expression in renal artery of Wistar, Wistar Kyoto, and spontaneously hypertensive rats.
    Bueno V; Palos M; Ronchi FA; Andrade MC; Ginoza M; Casarini DE
    Transplant Proc; 2004 May; 36(4):1001-3. PubMed ID: 15194348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The N-terminal active centre of human angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide.
    Oba R; Igarashi A; Kamata M; Nagata K; Takano S; Nakagawa H
    Eur J Neurosci; 2005 Feb; 21(3):733-40. PubMed ID: 15733091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do studies with ACE N- and C-domain-selective inhibitors provide evidence for a non-ACE, non-chymase angiotensin II-forming pathway?
    Husain A; Li M; Graham RM
    Circ Res; 2003 Jul; 93(2):91-3. PubMed ID: 12881473
    [No Abstract]   [Full Text] [Related]  

  • 15. Functional consequences of angiotensin-converting enzyme gene polymorphism on N-acetyl-Ser-Asp-Lys-Pro degradation and angiotensin II production.
    Azizi M; Junot C; Ezan E; Hallouin MC; Guyene T; Ménard J
    J Mol Med (Berl); 2002 Aug; 80(8):492-8. PubMed ID: 12185449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simulated interactions between angiotensin-converting enzyme and substrate gonadotropin-releasing hormone: novel insights into domain selectivity.
    Papakyriakou A; Spyroulias GA; Sturrock ED; Manessi-Zoupa E; Cordopatis P
    Biochemistry; 2007 Jul; 46(30):8753-65. PubMed ID: 17605472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin converting enzyme (ACE) and neprilysin hydrolyze neuropeptides: a brief history, the beginning and follow-ups to early studies.
    Skidgel RA; Erdös EG
    Peptides; 2004 Mar; 25(3):521-5. PubMed ID: 15134871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different contributions of the angiotensin-converting enzyme C-domain and N-domain in subjects with the angiotensin-converting enzyme II and DD genotype.
    van Esch JH; van Gool JM; de Bruin RJ; Payne JR; Montgomery HE; Hectors M; Deinum J; Dive V; Jan Danser AH
    J Hypertens; 2008 Apr; 26(4):706-13. PubMed ID: 18327080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE.
    Deddish PA; Marcic B; Jackman HL; Wang HZ; Skidgel RA; Erdös EG
    Hypertension; 1998 Apr; 31(4):912-7. PubMed ID: 9535414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.
    Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC
    J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.